UBS Group
MYOV

UBS Group’s Myovant Sciences Ltd. MYOV Stock Holding History

UBS Group’s Portfolio MYOV Stock Details MYOV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-411,137
Closed -$11.1M – 11317
2022
Q4 		$11.1M Buy
411,137
+382,529
+1,337% +$10.1M ﹤0.01% 1846
2022
Q3 		$515K Sell
28,608
-55,460
-66% -$885K ﹤0.01% 4311
2022
Q2 		$1.04M Sell
84,068
-67,713
-45% -$747K ﹤0.01% 3706
2022
Q1 		$2.02M Sell
151,781
-82,947
-35% -$1.11M ﹤0.01% 3411
2021
Q4 		$3.65M Buy
234,728
+98,190
+72% +$1.87M ﹤0.01% 3177
2021
Q3 		$3.06M Buy
136,538
+64,689
+90% +$1.42M ﹤0.01% 3183
2021
Q2 		$1.64M Sell
71,849
-48,614
-40% -$1.02M ﹤0.01% 3754
2021
Q1 		$2.48M Sell
120,463
-101,953
-46% -$2.32M ﹤0.01% 3343
2020
Q4 		$6.14M Buy
222,416
+120,752
+119% +$2.35M ﹤0.01% 2264
2020
Q3 		$1.43M Buy
101,664
+86,778
+583% +$1.61M ﹤0.01% 3373
2020
Q2 		$307K Buy
14,886
+10,449
+235% +$142K ﹤0.01% 4501
2020
Q1 		$34K Sell
4,437
-7,598
-63% -$85.2K ﹤0.01% 6129
2019
Q4 		$187K Buy
12,035
+4,885
+68% +$49.2K ﹤0.01% 5650
2019
Q3 		$37K Buy
7,150
+6,608
+1,219% +$49K ﹤0.01% 6372
2019
Q2 		$5K Sell
542
-650
-55% -$9.7K ﹤0.01% 7405
2019
Q1 		$28K Sell
1,192
-246
-17% -$5.03K ﹤0.01% 6015
2018
Q4 		$23K Buy
1,438
+146
+11% +$2.88K ﹤0.01% 6682
2018
Q3 		$34K Buy
+1,292
New +$29.2K ﹤0.01% 6453
2018
Q2 		– Sell
-1,025
Closed -$22K – 8351
2018
Q1 		$22K Buy
+1,025
New +$15.6K ﹤0.01% 6364
2017
Q4 		– Sell
-1,184
Closed -$18K – 8194
2017
Q3 		$18K Buy
1,184
+1,069
+930% +$13K ﹤0.01% 6540
2017
Q2 		$1K Sell
115
-1,628
-93% -$20.2K ﹤0.01% 7539
2017
Q1 		$20K Sell
1,743
-1,282
-42% -$14.7K ﹤0.01% 6147
2016
Q4 		$38K Buy
+3,025
New +$35.1K ﹤0.01% 6047

Other funds holding MYOV

HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

UBS Group's MYOV Position: Q1 2023 in Review

UBS Group sold out of Myovant Sciences Ltd. (MYOV) in Q1 2023, closing a stake of 411,137 shares — an estimated $11.1M sold.

UBS Group first reported a position in MYOV in Q4 2016 and held it in 23 quarters. The position peaked at $11.1M in Q4 2022. 2 funds tracked by Wall St. Rank hold MYOV as of Q1 2023.

  • UBS Group reported no remaining Myovant Sciences Ltd. position as of Q1 2023 after selling out during the quarter.
  • UBS Group sold 411,137 Myovant Sciences Ltd. shares in Q1 2023, an estimated $11.1M.
  • UBS Group first reported a position in Myovant Sciences Ltd. in Q4 2016 and held it in 23 quarters.
  • UBS Group's Myovant Sciences Ltd. position peaked at $11.1M in Q4 2022.
  • 2 funds tracked by Wall St. Rank held Myovant Sciences Ltd. as of Q1 2023.

Based on UBS Group's 13F filing for Q1 2023, filed 12 May 2023.